Dr Thomas Seisen talks about treatment option...

UROLUTS associate editor Dr. Cyrille Guillot-Tantay interviews Dr. Ahmed Albakr on the abstract he presented at AUA 2026 last month, “Evaluation of a novel midurethral sling for tissue compatibility and easier sling excision in porcine models”.Dr. Albakr elaborates on the rationa ...  Show more

In Episode 3, “Revalidation & lifelong learning” of the series “Start smart: EU-ACME for young urologists”, Prof. Marek Babjuk (CZ), Assoc. Prof. Juan Luis Vásquez (DK), Prof. Giorgio Ivan Russo (IT) and Dr. Loïc Baekelandt (BE) explore the importance of maintaining competencies ...  Show more

Join us for a discussion with Prof Paolo Ghia, MD, PhD, from Università Vita Salute San Raffaele, Milan (Italy), as he explores how precision medicine is transforming CLL treatment. In this episode, discover how precision medicine is used daily in CLL to decide the best managemen ...  Show more

This week, we shift our focus to talking about relapsed/refractory follicular lymphoma. In this episode, we will specifically discuss treatment options other than cellular therapy, which will be an u ...

Melanoma is a commonly encountered, often metastatic, disease in canine patients. In this episode of Clinician’s Brief Partner Podcast, Dr. Beth invites Dr. Timothy Fan to share advice on the clinical management of melanoma in practice. Dr. Fans offers insights on staging, sur ...

New FDA-approved therapies for BCG-refractory non-muscle invasive bladder cancer (NMIBC)–where do they fit in the treatment algorithm, and how do you administer them? This installment of the 2025 NMIBC Creator Weekend™ series features host Dr. Bogdana Schmidt, assistant professor ...  Show more